Clinical Research Directory
Browse clinical research sites, groups, and studies.
CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA
Sponsor: AstraZeneca
Summary
To fulfil the post-approval commitment of MFDS to conduct post-marketing surveillance, this study is designed to assess the known safety profile, identify previously unsuspected adverse reactions and to evaluate the effectiveness of Capivasertib under conditions of routine daily medical practice in Korea.
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
130
Start Date
2025-10-15
Completion Date
2029-12-30
Last Updated
2025-10-29
Healthy Volunteers
No
Conditions
Locations (8)
Research Site
Busan, South Korea
Research Site
Daejeon, South Korea
Research Site
Daejeon, South Korea
Research Site
Goyang-si, South Korea
Research Site
Guri-si, South Korea
Research Site
Incheon, South Korea
Research Site
Seoul, South Korea
Research Site
Uijeongbu-si, South Korea